Johns Hopkins is the first center in the U.S. to be approved for living donor HIV-positive to HIV-positive kidney transplants
Johns Hopkins hopes to become the first hospital in the United States to perform HIV-positive to HIV-positive organ transplants from living donors.
A comprehensive medical and psychological screening and evaluation to identify potential risks is done for any individual who is interested in donating an organ, and potential kidney donors are currently being evaluated for this medical milestone. A previous study led by Dorry Segev, associate professor of surgery at the Johns Hopkins University School of Medicine, found that long-term mortality was similar or lower for live kidney donors than their counterparts in the general public. Once a donor is identified, then a suitable recipient, who is currently on the kidney waiting list, will be selected and the procedures will be scheduled.